Manufacturers Life Insurance Company, The Bicycle Therapeutics PLC Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 129,705 shares of BCYC stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,705
Previous 97,392
33.18%
Holding current value
$1.91 Million
Previous $1.97 Million
49.21%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BCYC
# of Institutions
111Shares Held
40.8MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$138 Million2.28% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.55MShares$52.1 Million2.97% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.34MShares$34.4 Million9.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$33.1 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$28.7 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $436M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...